Sirolimus and secondary skin-cancer prevention in kidney transplantation.
about
Incidence, risk factors and outcomes of de novo malignancies post liver transplantationCutaneous Squamous Cell Carcinomas in Organ Transplant RecipientsSafety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant RecipientsSkin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?Corticosteroid and calcineurin inhibitor sparing regimens in kidney transplantationA systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipientsReviewing 15 years of experience with sirolimusLifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycinHPV-related cancers after solid organ transplantation in the United StatesEffect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data.The pros and the cons of mTOR inhibitors in kidney transplantation.From rapalogs to anti-aging formula.Hormesis and Defense of Infectious Disease.Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant RecipientsSkin cancer in organ transplant recipients: more than the immune system.The cutting edge of skin cancer in transplant recipients: scientific retreat of international transplant Skin Cancer Collaborative and Skin Cancer in Organ Transplant Patients EuropeMalignant and noninvasive skin tumours in renal transplant recipientsMerkel cell carcinoma in immunosuppressed patients.Selective anti-cancer agents as anti-aging drugsA randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients.Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients.Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis.Premalignant and Malignant Skin Lesions in Two Recipients of Vascularized Composite Tissue Allografts (Face, Hands)Rejuvenating immunity: "anti-aging drug today" eight years later.Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program).Melanoma in organ transplant recipients: incidence, outcomes and management considerations.Inhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse Skin.Recent progress in genetics of aging, senescence and longevity: focusing on cancer-related genes.Cancer in the transplant recipient.Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation.Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22.More than skin deep? Potential nicotinamide treatment applications in chronic kidney transplant recipients.Gerosuppression by pan-mTOR inhibitors.Skin changes following organ transplantation: an interdisciplinary challenge.An evaluation of sirolimus in renal transplantation.Exploring new frontiers: sirolimus as a pharmacokinetic modulator in advanced cancer patients.Update on the long-term complications of renal transplantation.Malignancies after pediatric kidney transplantation: more than PTLD?Synergism between mTOR pathway and ultraviolet radiation in the pathogenesis of squamous cell carcinoma and its implication for solid-organ transplant recipients.
P2860
Q26748580-25F1FF9A-794A-49B0-B3EF-0CCA1FE2DDAAQ26799460-364BAE78-EF47-4C33-813B-D0593CCEF753Q26799916-E754F32F-A081-4B57-B73D-9062470D1BEAQ26851436-EB240C0E-D080-4716-895A-773D9A75A816Q26992343-9E799290-D7DF-42FE-9971-A3BECFB96995Q27000107-C88D3AC7-F659-4F60-AF35-612ECBFC5260Q28080955-15034306-0474-4B9A-B4E5-91C7D496514BQ28307873-EA70A50D-FC16-4E25-8A83-C7583A39F7F2Q30580161-A9F0DEA9-1930-4453-8A40-C29AABF27260Q30871643-9C7B920F-46B4-4343-BB74-F129C868D09BQ33412367-77EEFD7F-9CB0-4A72-8450-D034C56BD438Q33829205-6E735238-EE8E-4C60-AE73-6794B4CF9A39Q33838971-75273A45-AA9E-4AE6-AEFD-CFD339409C07Q33873997-B8D73258-3D37-4D65-B813-72A7279E55ECQ33923227-BA41BAA9-C856-453F-98B0-6365936F72E4Q34111987-BE5AD528-BC53-4BE2-B033-6D98C57C5F54Q34268585-C70775DF-542C-4775-946F-32C3414566A3Q34309887-A8195199-BA64-453E-A9FB-D6A42220F036Q34392470-07D9A830-AFFC-47B4-BA32-EAC71B92C964Q34805919-8F0E5494-508D-43C0-B6CD-3621B86CFF6DQ36023899-F998B60F-FD26-436F-A059-6D2E0A8B5877Q36051817-E3E00105-FCE9-4040-BC29-E370A99E087FQ36209013-5874F59F-8998-46AE-AF06-ACE22B3DB5DCQ36260537-BC1C7312-DA5B-41A2-8F29-198E9D861C76Q36414149-589B121A-F665-4983-9D79-E38AA6FEF0CDQ36440261-A49403F4-A7A1-448C-B9E2-AA67C9AFED95Q36649878-04225665-7B10-4C61-B000-5ECB56B1E419Q36926098-6CAAD1A5-1FBC-42D6-ACD0-FE7DBEC594D9Q36938488-EAC5C3FF-5AB1-4E3A-80B6-DDE40E010B5EQ36964382-45AEA7E9-24D3-455B-BD30-D7794174FB30Q37184425-EA2DC15A-2236-4307-B004-564291788431Q37277272-1DADEFB6-305D-424E-B21F-EFEEE0E2A990Q37522572-184D8BC8-7AEC-41B4-B181-D41C506D0D20Q37610218-D88FA935-CCF6-45A6-9A60-72C47BB2598DQ37687958-CD888610-BD11-4BE9-A4D0-DF1D51ECF814Q38038696-F0C23B7D-4C04-4D93-BEFE-25511116862FQ38069181-B19652A8-4017-4663-A9D8-7C4212A293D0Q38104335-608D6CBB-A897-48D5-870A-BB8E7407B470Q38141838-34001F41-E1AC-4A7C-9A79-46D974226CF8Q38187197-B99C78AF-7433-4F4C-9222-41716806B50F
P2860
Sirolimus and secondary skin-cancer prevention in kidney transplantation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Sirolimus and secondary skin-cancer prevention in kidney transplantation.
@en
Sirolimus and secondary skin-cancer prevention in kidney transplantation.
@nl
type
label
Sirolimus and secondary skin-cancer prevention in kidney transplantation.
@en
Sirolimus and secondary skin-cancer prevention in kidney transplantation.
@nl
prefLabel
Sirolimus and secondary skin-cancer prevention in kidney transplantation.
@en
Sirolimus and secondary skin-cancer prevention in kidney transplantation.
@nl
P2093
P356
P1476
Sirolimus and secondary skin-cancer prevention in kidney transplantation.
@en
P2093
Adeline S Roux
Anabelle Brocard
Andreas L Serra
Anne Dompmartin
Claire Pouteil-Noble
Emmanuel Morelon
Eric Goffin
Evelyne Decullier
Günther F L Hofbauer
Isabelle Tromme
P304
P356
10.1056/NEJMOA1204166
P407
P577
2012-07-01T00:00:00Z